pentobarbital will decrease the extent or outcome of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Robust CYP3A4 inducers could reduce partiaprevir and ritonavir degrees, and so reduced efficacy of Viekira Pak